Concepedia

Author

Lalitha Kodandapani

Idera Pharmaceuticals (United States)

Also Known As

L. Kodandapani, Lalitha Kodandapani

13

Publications

623

Citations

10

H-Index

32

Concepts

All Affiliations

Idera Pharmaceuticals (United States)Novartis (Switzerland)University of Zurich
LK

About

Lalitha Kodandapani is an author at Idera Pharmaceuticals (United States) specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

332

2

Natural Sciences

6

6

372

3

Biochemistry

5

5

311

4

Chemical Biology

3

3

63

5

Cell Biology

1

1

143

Lalitha Kodandapani

×

10

Publications

618

Citations

10

H-Index

YearCitations

Bcl-xL Functions Downstream of Caspase-8 to Inhibit Fas- and Tumor Necrosis Factor Receptor 1-induced Apoptosis of MCF7 Breast Carcinoma Cells

Anu Srinivasan, Feng Li, Angela Wong,

Journal of Biological Chemistry

1998

160

The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis

Helen Blanchard, Lalitha Kodandapani, Peer R. E. Mittl,

Structure

1999

143

First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease

Steven D. Linton, Teresa Aja, Robert A. Armstrong,

Journal of Medicinal Chemistry

2005

105

Caspase-8 specificity probed at subsite S 4 :crystal structure of the caspase-8-Z-DEVD-cho complex 1 1Edited by R. Huber

Helen Blanchard, Mrudula Donepudi, Markus Tschopp,

Journal of Molecular Biology

2000

61

Structural and Functional Analysis of Caspase Active Sites

David Chéreau, Lalitha Kodandapani, Kevin J. Tomaselli,

Biochemistry

2003

51

Acyl dipeptides as reversible caspase inhibitors. Part 1: Initial Lead Optimization

Steven D. Linton, Donald S. Karanewsky, Robert J. Ternansky,

Bioorganic & Medicinal Chemistry Letters

2002

33

INTRAPLEURAL LOW-MOLECULAR-WEIGHT UROKINASE OR TISSUE PLASMINOGEN ACTIVATOR VERSUS SINGLE-CHAIN UROKINASE IN TETRACYCLINE-INDUCED PLEURAL LOCULATION IN RABBITS

Steven Idell, Ali Azghani, Shande Chen,

Experimental Lung Research

2007

21

Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimization

Steven D. Linton, Donald S. Karanewsky, Robert J. Ternansky,

Bioorganic & Medicinal Chemistry Letters

2002

17

Caspase‐8 Variant G Regulates Rheumatoid Arthritis <scp>Fibroblast‐Like</scp> Synoviocyte Aggressive Behavior

Cecilia Ansalone, Richard I. Ainsworth, Gyrid Nygaard,

ACR Open Rheumatology

2021

14

Structure–activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads

Brett R. Ullman, Teresa Aja, Ning Chen,

Bioorganic & Medicinal Chemistry Letters

2005

13

Page 1